Approved for 1 INDICATIONS AND USAGE EMCITATE is indicated for the treatment of peripheral thyrotoxicosis in adults and pediatric patients with monocarboxylate transporter 8 (MCT8) deficiency (Allan-Herndon-Dudley syndrome). Limitation of Use EMCITATE is not recommended for the treatment of primary hypothyroidism.. 12.1 Mechanism of Action Tiratricol is a thyroid hormone receptor (THR) agonist…
Loading full data from Know Your Drugs Institute…